Search

everythinglearnresearchcommunity

for

Search:↓

Two new enzymes, PAD-R11 and PAD-R4, were cloned and showed activity, with PAD-R11 resembling epidermal enzymes.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

MCPIP1 in myeloid cells is important for skin cancer development and healthy hair growth.

A new compound effectively inhibits human 5α-reductase 1.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.

Antiandrogens help improve developmental delays caused by valproic acid in rats.

Baricitinib is the most effective treatment for alopecia areata.

Pantothenic acid helps mink hair follicles grow by affecting certain cell signals.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Upadacitinib improved multiple immune-related conditions in one patient.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.